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A recent case of methylmercury poisoning
provided a dramatic example of a long latency
period between exposure and the onset of
clinical symptoms of poisoning (1). The vic-
tim was briefly exposed to dimethylmercury
in attempting to pipette this liquid form of
mercury. Although the transfer took place in
a fume hood, and the victim wore protective
gloves, she was exposed to an amount of
methylmercury that would ultimately prove
fatal. Despite this high single dose, the first
symptoms of poisoning did not occur until
150 days later.
The analysis of a single strand of scalp
hair revealed the progression of mercury levels
over the entire period from exposure to her
ultimate demise (Figure 1). The data points
were fitted with a pharmacokinetic model
consisting of a rising and a falling phase, each
characterized by a single exponential term.
The rising phase had a half-time of approxi-
mately 6 days. This period likely represents
the time needed for the metabolic conversion
of dimethylmercury to monomethylmercury,
as shown to occur in animal studies (2).
Monomethylmercury is known to be avidly
accumulated into scalp hair. Once incorpo-
rated into the formed elements of the hair
strand, its concentration remains constant.
The concentration in the newly formed hair
bears a constant ratio to the simultaneous
blood level (3).
The falling phase is represented by a
smooth curve with a half-time of about 74
days, consistent with methylmercury kinetics
in humans (4). This curve indicates that no
subsequent exposure took place, in agreement
with the clinical records. At the 150-day time
point, when symptoms first appeared, the
mercury level had dropped by a factor of
four, corresponding to the 74-day half-time.
During this period, the patient experienced
no ill effects and pursued her normal duties as
a professor of chemistry at Dartmouth
College. The exposure took place in the
month of August. It was not until the end of
December that the first ill effects appeared.
Thereafter, the full neurological syndrome of
severe methylmercury poisoning rapidly
developed. After just 2 weeks the patient was
severely affected and remained in this condi-
tion until her death a few months later. How
do we explain the 150-day latency period fol-
lowed by a sudden onset of severe methyl-
mercury poisoning?
Latencies in Acute
Methylmercury Poisoning
The neuropathology of methylmercury is well
described from previous cases (5). Focal
anatomical areas are affected (Figure 2). For
example, the small granule cells of the cere-
bellum are destroyed, but the neighboring
Purkinje cells are relatively unaffected. The
signs of incoordination (ataxia), typical of
severe poisoning, are probably due to damage
to this area of the brain. Constriction of the
visual fields results from the loss of neurons
from the visual cortex.
The severity of the damage is related to the
magnitude of the dose, as illustrated in Figure
3. These data are taken from an outbreak of
poisoning in the winter of 1971–1972 in rural
Iraq, where farmers and their families ingested
homemade bread made from seed wheat
treated with a methylmercury fungicide (7). As
the levels of methylmercury in hair increase,
the earliest symptom, a tingling sensation
(paresthesia), appears. With rising hair levels,
increasing proportions of the population are
affected. Ataxia is the next adverse effect to
appear, followed by difﬁculty in pronouncing
words (dysarthria), deafness, and ultimately
death. The peak hair level of about 1,000 ppm
in the Dartmouth case is consistent with the
finding in Iraq, where fatalities appeared at
hair levels above 800 ppm.
It is generally assumed that, as the dose
increases, more damage to the brain must take
place. If the severity of damage is dose depen-
dent, is the latency period also dose depen-
dent? A typical sequence of the development of
poisoning in Iraq is shown in Figure 4. The
contaminated bread was ingested over a period
of weeks. Many individuals stopped eating the
bread as a result of warnings from the public
health authorities. This was followed by a
latency period before the onset of symptoms.
Bakir et al. (7) reported that the length of the
latency period showed no decrease with rising
blood levels (Table 1). The average latency
periods fell within a range of approximately
16–38 days. In the Dartmouth case described
previously, the patient had a maximum hair
level (Figure 1) equal to the highest levels
reported in Iraq (Figure 3) and exhibited the
longest latency period. This finding is not
what one would expect intuitively. For exam-
ple, if mercury were reacting with a target mol-
ecule to produce its toxic effects, one would
expect that the higher the level of mercury, the
sooner the damage would appear.
Perhaps the latency period is due to the
slow production and accumulation of a toxic
metabolite. For example, methylmercury is
known to be converted to divalent inorganic
mercury in the brain over periods of months
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(9). However, as illustrated in Figure 5, one
would expect the buildup of inorganic mer-
cury to be faster at higher levels of methyl-
mercury, resulting in a shorter latency period.
It is possible that the rate of conversion to
inorganic mercury is rate limited and there-
fore occurs at a steady rate independent of the
level of methylmercury. However, we should
also have to assume that inorganic mercury is
the proximate toxic agent in methylmercury
poisoning. This assumption is contrary to evi-
dence in the literature (10).
Berlin et al. (11) noted that the distribu-
tion of methylmercury in the brain of squirrel
monkeys slowly changed over a 1-month
period. The change in distribution seemed to
be correlated with the onset of toxic effects.
However, the authors raised the caveat that
“it cannot be determined from the limited
material whether the redistribution causes the
toxic effects or results from it.” Certainly, it is
difﬁcult to understand how a toxic redistribu-
tion would take as long as 150 days with
brain levels of methylmercury falling during
this period.
It is as if methylmercury were acting as a
trigger. Once its concentration in brain
exceeds a certain threshold level, a slow process
would be initiated that ultimately results in cell
death. The rapid development of the full syn-
drome of poisoning suggests two possible
processes. Under one scenario, this process
takes roughly the same amount of time for the
different neuronal cells affected. The nature of
this process is unknown. It might, for example,
be the accumulation of a toxic protein, as is the
case in Alzheimer disease but taking place over
months instead of years. An alternate possibil-
ity, discussed in detail later in this article, is
that the population of neuronal cells embodies
a statistical distribution of susceptibility. In
this scenario, the more susceptible cells suc-
cumb ﬁrst. As they die, surviving cells assume
their function, but eventually, because of the
increased functional load and metabolic stress,
these cells also succumb. At some point, the
neuronal population has exhausted its capacity
to compensate for the cell loss and clinical
signs rapidly erupt.
It has been suggested (12) that methyl-
mercury might trigger the synthesis of a
protective molecule. For example, the synthesis
of glutathione can be induced by methyl-
mercury in the brains of rodents (13). This
molecule is known to be protective against
methylmercury damage to the brain (14).
However, it does not explain the continuation
of the induction process for a 150-day period.
A mechanistic explanation of the latency period
in severe acute poisoning remains elusive.
Latency after Low-Level
Chronic Exposure
Much longer latency periods are associated
with low-level chronic exposure to methyl-
mercury. Latency periods extending for sev-
eral years are illustrated in Figure 6 for both
human and nonhuman primates. Rice (15)
demonstrated that monkeys receiving a low
daily dose of methylmercury for the first 7
years of life developed no signs of poisoning
until 13 years of age, that is, after a latency
period of 6 years. The adverse effects were
mild, unlike the severe intoxications discussed
above, and consisted mainly of impaired dex-
terity and clumsiness in handling items of
food. Latency periods as long as 15 years have
been reported after the Minamata outbreak
[for details, see Igata (16)].
Evans et al. (17) conducted a long-term
study on nonhuman primates in which the
desired blood levels were quickly established
with priming doses and then maintained for
periods up to 1,400 days by weekly adminis-
tration. This study clearly demonstrated that
the latency period was dose dependent
(Figure 7). The length of the latency period
decreased with increasing blood levels, unlike
the pattern seen after acute severe doses.
A plausible mechanism for this second
type of latency period comes from a model
offered by Weiss and Simon (18). They pro-
posed that the normal loss of cells due to
aging over some portion of the human life
span can be accelerated by neurotoxic agents
(Figure 8). The model demonstrates how even
a slightly accelerated rate of loss can lead to a
signiﬁcant reduction of cell number and pre-
mature brain aging over a period of decades.
This concept may be applied to explain
the second type of latency period for methyl-
mercury. A toxic dose of mercury will cause
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Figure 1. The concentration of mercury in a single
strand of hair collected from a person exposed to
dimethylmercury at day 0. Reproduced from
Nierenberg et al. (1). ©1998 Massachusetts
Medical Society. All rights reserved.
Figure 2. Focal anatomical areas of an adult brain
affected by methylmercury. The black circles show
the localization and distribution of pathological
changes. Adapted from Tsubaki and Irukayama (6).
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Figure 3. The frequency of signs and symptoms of
methylmercury poisoning in a population exposed
in the Iraq outbreak. Modiﬁed from Bakir et al. (7). 
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Figure 4. The sequence of appearance of signs and
symptoms of methylmercury poisoning in a victim
in the Iraq outbreak. Reproduced from Clarkson (8)
with permission of the American Journal of
Clinical Nutrition. © Am J Clin Nutri. American
Society for Clinical Nutrition.
Table 1. Blood levels of mercury, period of ingestion of contaminated bread, and the length of latency
period. 
Concentration of  Mean period of  Mean latency Number of 
mercury in blood (ng/mL) ingestion (days) period (days) persons exposed
0–100 43 — 21
101–500 43 — 19
501–1,000 43 16 19
1,001–2,000 41 18 17
2,001–3,000 55 26 25
3,001–4,000 58 32 17
Length of latency period is time between the end of contaminated bread consumption and the appearance of signs and
symptoms of methylmercury poisoning. Data from Bakir et al. (7).Environmental Health Perspectives • VOLUME 110 | SUPPLEMENT 5 | OCTOBER 2002 853
an initial cell loss, which may or may not
reduce the number of target cells to the point
at which overt symptoms appear. Over time,
the aging process will further reduce the
number of cells until those that remain are
too few to sustain function, and overt effects
then erupt. In this situation the higher the
initial dose, the greater the loss of cells due to
the action of mercury. This will in turn
reduce the latency period due to aging. This
model explains the dose dependency of the
second type of latency period.
The outcome of this “aging” latency
period will be affected by the degree of cell
loss after the initial insult. The aging process
should result in increasingly severe effects as
cell number continues to fall. Such an out-
come is consistent with the ﬁndings of Evans
et al. (17) in nonhuman primates and in the
human cases from Minamata.
Additional Possibilities
and Processes
We must also entertain the possibility of
another kind of process that may account for
the long-latency phenomenon seen with the
Dartmouth patient described in the introduc-
tory remarks. To some degree, it mimics the
process presumed to underlie Parkinson dis-
ease. Most observers agree that the appearance
of clinical signs is merely the ultimate phase of
a neurodegenerative process whose inception
might even be traced to events occurring dur-
ing early development (19). The clinical signs
are believed to emerge after the death of
60–90% of the pigmented, dopamine-pro-
ducing cells in the substantia nigra pars com-
pacta. The long latency is attributed to the
ability of the remaining cells to compensate
for the functions of the vanished cells (20).
Figure 9 models such a process. It depicts the
relationship between the number of cells
remaining and the amount of neurotrans-
mitter (or other functional output) required of
each remaining cell to compensate for the lost
cells. The empirical data indicate that such a
compensatory process does occur with
Parkinson disease, but that eventually, of
course, it breaks down. The Dartmouth case
of dimethylmercury poisoning described
above may reﬂect such a process. During the 5
months preceding the onset of clinical signs, it
is conceivable that brain cells were undergoing
continuous destruction. Only after the com-
pensatory mechanisms began to fail under
their burden, we might presume, did the
extent of destruction assert itself.
The breakdown process itself, moreover,
might have engendered further, independent
damage. Table 2 outlines a hypothetical
sequence of events analogous to what some
observers believe applies to Parkinson disease
and to post-polio syndrome. As the surviving
cells increase neurotransmitter output or
develop additional synaptic connections to
compensate for those no longer functional,
they may also produce greater amounts of
toxic metabolic products or stress the parent
cells, so that the entire process becomes
trapped in a positive feedback loop.
Other explanations, which do not exclude
the one described above, may also be at work.
As pointed out earlier, nerve cells are not all
equally vulnerable and display a population
distribution of susceptibility. We can assume
that the more susceptible cells (perhaps the
smaller ones) die first. The less susceptible,
remaining cells should be able to take on the
roles of those no longer functioning. The
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brain from 25 years of age onward. The uppermost
curve depicts “normal” aging. The lower three
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in the rate of loss. From Weiss and Simon (18) with
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Figure 9. Compensation for cell loss. The figure
depicts the relationship between the number of
cells remaining and the amount of neurotransmitter
(or other functional output) required of each
remaining cell to compensate for the lost cells.
Table 2. Components of a multistage neurodegen-
erative process.
Erosion of cell numbers
Increased transmitter production per cell
Accumulation of toxic products of synthesis
Functional exhaustion
Deathbrain is built with considerable redundancy;
even adult brains, which presumably lack the
suppleness of developing brains, often make
remarkable recoveries after strokes of consid-
erable extent. Post-polio syndrome is perhaps
one example of such a selective destruction.
Decades after having apparently recovered
from an acute poliomyelitis infection, those
affected begin to experience a reappearance of
the original motor deficits. Most observers
credit this phenomenon to “overworked” cells
in the spinal cord.
Another example of late onset also comes
from polio. Martyn et al. (21) correlated the
incidence of amyotrophic lateral sclerosis
(motoneuron disease) in U.K. counties dur-
ing the 1960s with the incidence of polio in
the 1930s. They found a signiﬁcant relation-
ship and explained it as follows:
We suggest that motoneuron disease is a rare and
delayed consequence of an infection with poliovirus
that affects the central nervous system and causes
loss of motoneurons but is not usually severe
enough to cause motor symptoms or paralysis at
the time of the acute illness.
Common Themes
We have reviewed three varieties of outcomes,
characterized by three different patterns of
delayed neurotoxicity between exposure and
the onset of detectable signs. The first is
exemplified by the puzzling case of the
chemist whose brief exposure to an eventually
fatal dose of dimethylmercury preceded the
emergence of clinical signs by 150 days. The
puzzle arises from the prolonged latency
before the onset of unequivocal neurotoxicity,
which covered a period during which blood
and hair levels fell continuously. The dose did
not, in this instance, make the poison, so to
speak, in apparent violation of a cherished
principle of traditional toxicology.
A second pattern is illustrated by neuro-
degenerative disorders such as Parkinson
disease and post-polio syndrome and exem-
pliﬁed, too, by low-level chronic exposure to
methylmercury. In these instances, we
assume an underlying pathological process
whose consequences remain submerged
because of the innate redundancy of the
brain. Only after the compensatory mecha-
nisms have been overwhelmed, sometimes in
combination with spontaneous loss of func-
tion due to aging, do the overt signs of
damage become evident.
The third pattern is exemplified by the
mass chemical disaster in Iraq in the winter of
1971–1972. Here, seed wheat treated with a
methylmercury fungicide was distributed to a
rural population that then used it to make
homemade bread and triggered an epidemic
of poisoning striking tens of thousands of
individuals. From tracking the victims, whose
exposures extended over a period of about 3
months, the kind of paradoxical result seen in
the case of the Dartmouth chemist was also
seen in this population: higher blood levels of
mercury, despite inﬂicting more serious dam-
age, also took longer to produce visible signs
than did lower blood and hair levels.
Conclusions
The question we posed is whether similar
mechanisms underlie all three patterns. The
commonalities are obvious: manifestations of
damage emerge only after compensatory
processes have been exhausted. The unresolved
conundrum comes from the Iraq example, in
which the latency period tended to lengthen
with increasing blood levels. Such a phenome-
non is not as uncommon as it seems. Cory-
Slechta et al. (22), for example, observed that
higher doses of lead acetate to rats trained on
an operant procedure evoked longer latencies
to diminished performance than did lower
doses. One possible although speculative expla-
nation may be related to a phenomenon gain-
ing wider recognition in toxicology: namely,
nonmonotonic dose–response relationships.
Several recent reviews [e.g., Calabrese and
Baldwin (23)] have pointed out the frequent
occurrence of U-shaped dose–response func-
tions in the life sciences. Their shape conﬂicts
with the traditional assumption of direct
dose–response relationships. Several possibili-
ties have been offered to account for the shape
of these functions. Most rely on the concept of
hormesis, which asserts that low-level expo-
sures stimulate compensatory processes that, in
essence, overshoot and confer an added mea-
sure of protection. But the mirror image of
hormesis can also prevail, giving rise to a situa-
tion in which only high-level exposures invoke
compensatory processes. In this instance, low-
level exposures are more likely than high-level
exposures to show evidence of adverse
effects or, at least, to show them more rapidly.
Such phenomena have been observed with
endocrine disruptors [e.g., (24)].
If any lesson is to be derived from the
examples discussed in this article, it is that the
conventional tenets of toxicology need to be
observed with a considerable degree of skepti-
cism. We should be convinced, not by dogma,
but by a deep understanding of mechanisms.
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